ENDRA Life Sciences Inc. SEC filings NDRA
ENDRA Life Sciences Inc. has 544 filings in SEC EDGAR's recent list, going back to Aug 9, 2016. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Form 425 | Oct 26, 2026 | — |
| S-4 | Registration for a merger or exchange | Oct 2, 2026 | — |
| 425 | Current report | Oct 1, 2026 | — |
| 8-K |
Current report
Material agreement
|
Oct 1, 2026 | Oct 1, 2026 |
| 425 | Form 425 | Sep 25, 2026 | — |
| 425 | Form 425 | Sep 14, 2026 | — |
| 425 | Filing | Sep 9, 2026 | — |
| 425 | Form 425 | Sep 9, 2026 | — |
| 425 | Form 425 | Aug 21, 2026 | — |
| 425 | Filing | Aug 20, 2026 | — |
| 425 | Current report | Aug 17, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 425 | Filing | Aug 6, 2026 | — |
| 425 | Filing | Aug 5, 2026 | — |
| 425 | Filing | Aug 4, 2026 | — |
| 425 | Filing | Jul 22, 2026 | — |
| 425 | Filing | Jul 22, 2026 | — |
| 425 | Form 425 | Jul 17, 2026 | — |
| 425 | Form 425 | Jul 17, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 9, 2026 | Jul 8, 2026 |
| 425 | Current report | Jun 26, 2026 | — |
| 8-K |
Current report
Material agreement, Change in control, Regulation FD disclosure, Other events
|
Jun 26, 2026 | Jun 25, 2026 |
| 425 | Filing | Jun 25, 2026 | — |
| 425 | Current report | Jun 25, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 25, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 28, 2026 | May 27, 2026 |
| RW | Withdrawal request | May 26, 2026 | — |
| S-8 | Employee stock plan registration | May 15, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Listing notice
|
Apr 21, 2026 | Apr 20, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Mar 25, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Dec 15, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 28, 2025 | Nov 28, 2025 |
| 424B4 | Prospectus | Nov 26, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| S-3 | Shelf registration | Nov 6, 2025 | — |
| 8-K |
Current report
Material agreement
|
Oct 30, 2025 | Oct 29, 2025 |
| 424B5 | Prospectus supplement | Oct 30, 2025 | — |
| ARS | Annual report to shareholders | Oct 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Oct 28, 2025 | — |
| DEF 14A | Proxy statement | Oct 28, 2025 | Dec 31, 2024 |
| D | Filing | Oct 24, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2025 | Oct 23, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 17, 2025 | Dec 31, 2024 |
| 8-K/A |
Amended current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure, Other events
|
Oct 15, 2025 | Oct 10, 2025 |
| 8-K | Current report | Oct 15, 2025 | Oct 10, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| S-1/A | Amended registration statement | Jul 25, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 23, 2025 | Jul 23, 2025 |
| S-1/A | Amended registration statement | Jul 16, 2025 | — |
| 8-K |
Current report
Results of operations
|
Jul 9, 2025 | Jul 9, 2025 |
| S-1 | Registration statement | Jul 9, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Listing notice
|
May 30, 2025 | May 27, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| DRS | Filing | May 9, 2025 | — |
| 10-K/A | Amended annual report | Apr 7, 2025 | Dec 31, 2024 |
| S-8 | Employee stock plan registration | Apr 2, 2025 | — |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 22, 2024 | Nov 22, 2024 |
| 10-Q/A | Amended quarterly report | Nov 21, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2024 | Nov 15, 2024 |
| NT 10-Q | Form nt 10-q | Nov 15, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Nov 5, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Oct 29, 2024 | Oct 28, 2024 |
| DEFA14A | Additional proxy material | Sep 17, 2024 | — |
| DEF 14A | Proxy statement | Sep 16, 2024 | Sep 6, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 6, 2024 | Sep 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 28, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 23, 2024 | Aug 22, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 16, 2024 | Aug 16, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 13, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Aug 9, 2024 | Aug 5, 2024 |
| DEFA14A | Additional proxy material | Jul 17, 2024 | — |
| 8-K |
Current report
Listing notice
|
Jul 17, 2024 | Jul 15, 2024 |
| ARS | Annual report to shareholders | Jun 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Jun 25, 2024 | — |
| DEF 14A | Proxy statement | Jun 25, 2024 | Aug 6, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 12, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 6, 2024 | Jun 4, 2024 |
| 424B3 | Prospectus | Jun 5, 2024 | — |
| EFFECT | Filing | Jun 4, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| S-1/A | Amended registration statement | May 31, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 20, 2024 | May 20, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2024 | May 10, 2024 |
| S-1/A | Amended registration statement | May 10, 2024 | — |
| 8-K |
Current report
Listing notice
|
May 3, 2024 | May 3, 2024 |
| UPLOAD | Letter from the SEC | Apr 29, 2024 | — |
| S-1 | Registration statement | Apr 19, 2024 | — |
| EFFECT | Filing | Apr 3, 2024 | — |
| 424B5 | Prospectus supplement | Apr 3, 2024 | — |
| 424B5 | Prospectus supplement | Apr 3, 2024 | — |
| CORRESP | Letter to the SEC | Apr 1, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| S-3/A | Form s-3/a | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| UPLOAD | Letter from the SEC | Feb 23, 2024 | — |
| S-3 | Shelf registration | Feb 14, 2024 | — |
| 424B3 | Prospectus | Dec 29, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 424B5 | Prospectus supplement | Aug 14, 2023 | — |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Aug 10, 2023 | Aug 9, 2023 |
| DEFA14A | Additional proxy material | Jul 25, 2023 | — |
| 8-K |
Current report
Other events
|
Jul 25, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Other events
|
Jul 6, 2023 | Jul 6, 2023 |
| DEFA14A | Additional proxy material | Jul 6, 2023 | — |
| ARS | Annual report to shareholders | May 24, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 24, 2023 | — |
| DEF 14A | Proxy statement | May 24, 2023 | Jul 6, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 2, 2023 | Apr 27, 2023 |
| 424B5 | Prospectus supplement | Apr 28, 2023 | — |
| S-1MEF | Filing | Apr 28, 2023 | — |
| EFFECT | Filing | Apr 27, 2023 | — |
| CORRESP | Letter to the SEC | Apr 24, 2023 | — |
| CORRESP | Letter to the SEC | Apr 24, 2023 | — |
| S-1/A | Amended registration statement | Apr 19, 2023 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 18, 2023 | Apr 18, 2023 |
| S-1/A | Amended registration statement | Apr 18, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2023 | — |
| S-1 | Registration statement | Mar 30, 2023 | — |
| S-8 | Employee stock plan registration | Mar 16, 2023 | — |
| 10-K | Annual report | Mar 16, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2023 | Mar 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2022 | Dec 21, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 19, 2022 | Dec 16, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 8, 2022 | Dec 8, 2022 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Dec 2, 2022 | Nov 29, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| DEFA14A | Additional proxy material | Oct 17, 2022 | — |
| DEF 14A | Proxy statement | Oct 17, 2022 | Nov 29, 2022 |
| PRE 14A | Preliminary proxy statement | Sep 27, 2022 | Nov 29, 2022 |
| 8-A12G | Form 8-a12g | Sep 27, 2022 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Sep 27, 2022 | Sep 27, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 22, 2022 |
| DEFA14A | Additional proxy material | Jun 21, 2022 | — |
| DEFA14A | Additional proxy material | May 17, 2022 | — |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 25-NSE | Delisting notice | May 12, 2022 | — |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 2, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 22, 2022 | Apr 21, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 21, 2022 | Apr 21, 2022 |
| 424B5 | Prospectus supplement | Mar 30, 2022 | — |
| S-8 | Employee stock plan registration | Mar 30, 2022 | — |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 10, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jan 7, 2022 | Jan 5, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jun 21, 2021 | Jun 21, 2021 |
| 424B5 | Prospectus supplement | Jun 21, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Jun 15, 2021 | Jun 9, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2021 | Jun 8, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 17, 2021 | May 17, 2021 |
| EFFECT | Filing | May 3, 2021 | — |
| CORRESP | Letter to the SEC | Apr 29, 2021 | — |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Apr 27, 2021 | Apr 27, 2021 |
| UPLOAD | Letter from the SEC | Mar 30, 2021 | — |
| S-8 | Employee stock plan registration | Mar 25, 2021 | — |
| S-3 | Shelf registration | Mar 25, 2021 | — |
| 10-K | Annual report | Mar 25, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2021 | Mar 5, 2021 |
| 8-K |
Current report
Material agreement
|
Feb 19, 2021 | Feb 19, 2021 |
| 424B5 | Prospectus supplement | Feb 19, 2021 | — |
| 8-K |
Current report
Other events
|
Feb 3, 2021 | Feb 2, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Other events
|
Dec 30, 2020 | Dec 28, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 21, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 18, 2020 | Dec 15, 2020 |
| 424B5 | Prospectus supplement | Dec 17, 2020 | — |
| 424B5 | Prospectus supplement | Dec 15, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NDRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ann Arbor, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1681682
- Former names
- Endra Inc. (until Sep 21, 2016)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.